Al-Zahir, Mohammed Z.
Chan, Kwan-Leung
Article History
Accepted: 16 August 2024
First Online: 26 August 2024
Declarations
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: Dr. Al-Zahir has nothing to disclose. Dr. Chan reports being on the Data Safety Monitoring Board of two trials (COPAS and EVOID-AS). COPAS is a pilot study initiated locally testing the effect of colchicine on progression of aortic stenosis, and EVOID-AS is a multi- center multinational study on the progression of aortic stenosis. He also reports being a member of task force on echo accreditation, Accreditation Canada and being a member of Cardiogenetics Expert Group, Ministry of Health, province of Ontario.